Piercarla C. Schinco

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

Journal: Blood transfusion = Trasfusione del sangue

Published: February 20, 2019

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

Journal: Blood transfusion = Trasfusione del sangue

Published: September 18, 2018

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.

Journal: Stem cell reports

Published: June 28, 2018

A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 20, 2017

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Journal: Advances in therapy

Published: December 24, 2016

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Journal: Blood transfusion = Trasfusione del sangue

Published: December 12, 2016

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.

Journal: Thrombosis and haemostasis

Published: March 09, 2015

Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.

Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: January 08, 2015

Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.

Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 28, 2014

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 26, 2013

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.

Journal: Seminars in thrombosis and hemostasis

Published: September 10, 2013

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Journal: Blood

Published: August 09, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026